CorVel Corp

CorVel Corp(CRVL)の株式分析

$80.710

-0.597 (-0.74%)終値時点

Loading chart…
高値
81.500
始値
80.770
出来高加重平均価格
80.71
出来高
126.22K
時価総額
4.32B
安値
79.930
売買代金
10.19M
EV/EBITDA(TTM)
0.00

CorVel Corporation applies technology, including artificial intelligence, machine learning and natural language processing, to enhance the management of episodes of care and the related health-care costs. The Company partners with employers, third-party administrators, insurance companies and government agencies to assist its customers in managing the medical costs of workers compensation, group health and auto insurance, and in monitoring the quality of care provided to claimants. Its services include claims management, bill review, preferred provider networks, utilization management, case management, pharmacy services, directed care and Medicare services. It delivers its solutions in three ways - as a fully integrated claims-management program, as discrete standalone services, or as targeted add-ons that enhance an existing client workflow. Integrated, end-to-end bundled programs are designed primarily for buyers such as self-insured employers who want a single, turnkey partner.

www.corvel.com

AI分析 of CorVel Corp (CRVL)

買い

CorVel Corp is a good buy right now due to its recent strong financial performance, with a Q1 net profit of $32.22 million and an EPS of $0.63, both showing significant year-over-year growth. Additionally, the RSI is at 77.48, indicating strong momentum, while the stock has shown a 21.22% year-to-date increase, reflecting positive market sentiment. The main risk is the high forward P/E of 23.75, suggesting that the stock may be overvalued if growth expectations are not met.

バリュエーション指標

CorVel Corp(CRVL)の現在の予想PERは23.75で、5年平均は90.99です。

予想PER

割安
5年平均 P/E
90.99
現在のP/E
23.75
割高
130.79
割安
51.19

予想EV/EBITDA

大幅な割安
5年平均 EV/EBITDA
0.00
現在のEV/EBITDA
0.00
割高
0.00
割安
0.00

予想PSR

大幅な割安
5年平均 P/S
7.02
現在のP/S
0.00
割高
8.94
割安
5.09

CRVL を保有するクジラ

K

Kayne Anderson Rudnick Investment Management, LLC

+ を保有CRVL

-2.78%

3か月リターン

イベントタイムライン

2026-06-01 (ET)

16:40:00

CorVel Appoints Sarah Scott as CEO

2026-05-20 (ET)

06:20:00

Q4 Revenue Reaches $248.54M

2026-02-03 (ET)

06:20:00

Q3 Revenue Reaches $236M vs. $228M Last Year

2025-02-13 (ET)

06:36:59

CorVel appoints Scott as Executive Vice President of Product

2024-12-24 (ET)

12:16:10

CorVel announces effectiveness of three-for-one forward stock split

ニュース

CRVL のよくある質問 — Alphio AI が回答

CorVel Corporation applies technology, including artificial intelligence, machine learning and natural language processing, to enhance the management of episodes of care and the related health-care costs. The Company partners with employers, third-party administrators, insurance companies and government agencies to assist its customers in managing the medical costs of workers compensation, group health and auto insurance, and in monitoring the quality of care provided to claimants. Its services include claims management, bill review, preferred provider networks, utilization management, case management, pharmacy services, directed care and Medicare services. It delivers its solutions in three ways - as a fully integrated claims-management program, as discrete standalone services, or as targeted add-ons that enhance an existing client workflow. Integrated, end-to-end bundled programs are designed primarily for buyers such as self-insured employers who want a single, turnkey partner. It operates in the Healthcare sector (INSURANCE AGENTS, BROKERS & SERVICE industry).

CorVel Corp is a good buy right now due to its recent strong financial performance, with a Q1 net profit of $32.22 million and an EPS of $0.63, both showing significant year-over-year growth. Additionally, the RSI is at 77.48, indicating strong momentum, while the stock has shown a 21.22% year-to-date increase, reflecting positive market sentiment. The main risk is the high forward P/E of 23.75, suggesting that the stock may be overvalued if growth expectations are not met.

コミュニティ

もっと見る ↗

投稿はまだありません

登録またはログインして議論に参加

本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。

取引を始める